GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)

INR 79.0

(-2.71%)

Long Term Debt Summary of GENOMIC VALLEY BIOTECH LIMITED

  • GENOMIC VALLEY BIOTECH LIMITED's latest annual long term debt in 2023 was - INR , down 0.0% from previous year.
  • GENOMIC VALLEY BIOTECH LIMITED's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
  • GENOMIC VALLEY BIOTECH LIMITED reported annual long term debt of - INR in 2022, down 0.0% from previous year.
  • GENOMIC VALLEY BIOTECH LIMITED reported annual long term debt of - INR in 2021, down -100.0% from previous year.
  • GENOMIC VALLEY BIOTECH LIMITED reported quarterly long term debt of - INR for 2023 Q3, down 0.0% from previous quarter.
  • GENOMIC VALLEY BIOTECH LIMITED reported quarterly long term debt of - INR for 2023 FY, down 0.0% from previous quarter.

Annual Long Term Debt Chart of GENOMIC VALLEY BIOTECH LIMITED (2023 - 2019)

Historical Annual Long Term Debt of GENOMIC VALLEY BIOTECH LIMITED (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - INR 0.0%
2022 - INR 0.0%
2021 - INR -100.0%
2020 15.47 Million INR 4.62%
2019 14.78 Million INR 0.0%

Peer Long Term Debt Comparison of GENOMIC VALLEY BIOTECH LIMITED

Name Long Term Debt Long Term Debt Difference
Alfavision Overseas (India) Limited 1.35 Billion INR 100.0%
Biocon Limited 129.32 Billion INR 100.0%
Blue Jet Healthcare Limited 3.79 Million INR 100.0%
Concord Biotech Limited 18.87 Million INR 100.0%
Dishman Carbogen Amcis Limited 2.45 Billion INR 100.0%
FERMENTA BIOTECH LIMITED 425.36 Million INR 100.0%
Lyka Labs Limited 429.06 Million INR 100.0%
Panacea Biotec Limited 209.9 Million INR 100.0%
SAMSRITA LABS LIMITED - INR NaN%
Servoteach Industries Limited 5059.00 INR 100.0%
SMS Lifesciences India Limited 331.45 Million INR 100.0%
Supriya Lifescience Limited 50.2 Million INR 100.0%
Syngene International Limited 1 Billion INR 100.0%
TAKE Solutions Limited 7.5 Million INR 100.0%
Titan Biotech Limited 4.53 Million INR 100.0%
Transgene Biotek Limited 50.79 Million INR 100.0%
Vanta Bioscience Limited 488.01 Million INR 100.0%